|
Volumn 5, Issue 4, 2002, Pages 326-328
|
Cessation of the WHI and WISDOM trials: A New Zealand perspective
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CONJUGATED ESTROGEN;
ESTROGEN;
ALZHEIMER DISEASE;
ATHEROSCLEROSIS;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
COGNITION;
COLORECTAL CANCER;
DRUG EFFECT;
DRUG RESEARCH;
ESTROGEN THERAPY;
HORMONE SUBSTITUTION;
HUMAN;
LONG TERM CARE;
MASS MEDIUM;
MENOPAUSE;
MONKEY;
NEW ZEALAND;
NOTE;
OSTEOARTHRITIS;
PRIORITY JOURNAL;
PUBLIC HEALTH;
QUALITY OF LIFE;
RISK BENEFIT ANALYSIS;
|
EID: 0036970076
PISSN: 13697137
EISSN: None
Source Type: Journal
DOI: 10.1080/cmt.5.4.326.328 Document Type: Note |
Times cited : (2)
|
References (10)
|